Customer updates during COVID pandemic Click Here >

2020 June 23 - Knowledge Resource Series #3 Biomarker Development Webinar
Christopher Bunker, Ph.D., MBA
Senior Director, Business Development, Advanced Cell Diagnostics
Watch Video:
Outline:

RNAscope in situ hybridization (ISH) platforms are utilized widely for high resolution tissue-based and cell-specific analysis of targets and biomarkers. ACD’s RNAscope ISH platform is clinically validated and enable quantitative expression analysis that has proven repeatedly to better stratify treatment-responsive and non-responsive patients in novel therapeutic clinical trials compared to more established methods, like IHC and qPCR. RNAscope is often more sensitive than IHC and provides cell-specific biomarker data in complex tissue microenvironments that qPCR cannot. A further advantage is speed. RNAscope biomarker assays can be verified and ready for use on clinical biopsies in a matter of weeks.

Learning Objectives:
  • Quantifiable, single-molecule detection of biomarker RNA in fixed biopsies
  • Superior performance against established methods, e.g., IHC, qPCR
  • Multiplexed analysis for immuno-oncology biomarkers
  • Application in small molecule, biologic and cell therapy biomarkers

 

X
Contact Us

Complete one of the two forms below and we will get back to you.

Advanced Cell Diagnostics

Our new headquarters office starting May 2016:

7707 Gateway Blvd.  
Newark, CA 94560
Toll Free: 1 (877) 576-3636
Phone: (510) 576-8800
Fax: (510) 576-8798

 

Bio-Techne

19 Barton Lane  
Abingdon Science Park
Abingdon
OX14 3NB
United Kingdom
Phone 2: +44 1235 529449
Fax: +44 1235 533420

 

 

Advanced Cell Diagnostics China

Building 15, No. 26 Xihuan South Road
Beijing Economic-Technological Development Area
Beijing, China, Zip code: 100176

400-966-1796
info_china.ACD@bio-techne.com
For general information: Leon.Li@bio-techne.com
Web: www.acdbio.com/cn

For general information: Info.ACD@bio-techne.com
For place an order: order.ACD@bio-techne.com
For product support: support.ACD@bio-techne.com
For career opportunities: hr.ACD@bio-techne.com